Brain pathology in mucopolysaccharidoses (MPS) patients with neurological forms

Brain pathology in mucopolysaccharidoses (MPS) patients with neurological forms

Show other versions (1)

Mucopolysaccharidoses (MPS) are the group of lysosomal storage disorders caused by deficiencies of enzymes involved in the stepwise degradation of glycosaminoglycans. To identify brain pathology common for neurological MPS, we conducted a comprehensive analysis of brain cortex tissues from post-mort...

Full description

Bibliographic Details
Main Authors:	Viana, GM, Priestman, D, Platt, FM, Khan, S, Tomatsu, S, Pshezhetsky, AV
Format:	Journal article
Language:	English
Published:	MDPI 2020

Similar Items

Brain Pathology in Mucopolysaccharidoses (MPS) Patients with Neurological Forms
by: Viana, GM, et al.
Published: (2020)

Epidemiology of Mucopolysaccharidoses Update
by: Betul Celik, et al.
Published: (2021-02-01)

Evading the AAV Immune Response in Mucopolysaccharidoses
by: Matthew Piechnik, et al.
Published: (2020-05-01)

Glucosamine amends CNS pathology in mucopolysaccharidosis IIIC mouse expressing misfolded HGSNAT
by: Pan, X, et al.
Published: (2022)

Hearing Loss in Mucopolysaccharidoses: Current Knowledge and Future Directions
by: Jeremy Wolfberg, et al.
Published: (2020-08-01)

Glycosaminoglycans as Biomarkers for Mucopolysaccharidoses and Other Disorders
by: Paige C. Amendum, et al.
Published: (2021-08-01)

Mucopolysaccharidoses and the blood–brain barrier
by: Onur Sahin, et al.
Published: (2022-09-01)

Mucopolysaccharidoses: Cellular Consequences of Glycosaminoglycans Accumulation and Potential Targets
by: Andrés Felipe Leal, et al.
Published: (2022-12-01)

Diagnosis of Mucopolysaccharidoses
by: Francyne Kubaski, et al.
Published: (2020-03-01)

Leukocyte Imbalances in Mucopolysaccharidoses Patients
by: Nuno Lopes, et al.
Published: (2023-06-01)

Diagnosis of Mucopolysaccharidoses and Mucolipidosis by Assaying Multiplex Enzymes and Glycosaminoglycans
by: Nivethitha Arunkumar, et al.
Published: (2021-07-01)

Elevated LysoGb3 Concentration in the Neuronopathic Forms of Mucopolysaccharidoses
by: Galina Baydakova, et al.
Published: (2020-03-01)

Functional independence of Taiwanese patients with mucopolysaccharidoses
by: Chung‐Lin Lee, et al.
Published: (2019-08-01)

Pathogenesis of Mucopolysaccharidoses, an Update
by: Simona Fecarotta, et al.
Published: (2020-04-01)

Bone Biomarkers in Mucopolysaccharidoses
by: Akari Nakamura-Utsunomiya
Published: (2021-11-01)

Orthopaedic challenges for mucopolysaccharidoses
by: Andrea Borgo, et al.
Published: (2018-11-01)

Oropharyngeal Dysphagia in Mucopolysaccharidoses: Evidence from Videofluoroscopic Swallowing Study
by: Luciana Carneiro, et al.
Published: (2022-12-01)

Atypical corneal clouding in mucopolysaccharidoses
by: Mary Stephen, et al.
Published: (2023-01-01)

Current and new therapies for mucopolysaccharidoses
by: Monica Penon-Portmann, et al.
Published: (2023-02-01)

Specific GAG ratios in the diagnosis of mucopolysaccharidoses
by: Déborah Mathis, et al.
Published: (2024-03-01)

Oxidative Stress in Mucopolysaccharidoses: Pharmacological Implications
by: Karolina Pierzynowska, et al.
Published: (2021-09-01)

Assumption of heparin-induced thrombocytopenia in mucopolysaccharidoses
by: Liliya Aleksandrovna Osipova, et al.
Published: (2021-08-01)

Differences in MPS I and MPS II Disease Manifestations
by: Christiane S. Hampe, et al.
Published: (2021-07-01)

Neuronopathic Types of Mucopolysaccharidoses: Pathogenesis and Emerging Treatments
by: L. A. Osipova, et al.
Published: (2015-11-01)

The Anesthetic Strategy for Patients with Mucopolysaccharidoses: A Retrospective Cohort Study
by: Hsuan-Chih Lao, et al.
Published: (2022-08-01)

Neurological Disease Modeling Using Pluripotent and Multipotent Stem Cells: A Key Step towards Understanding and Treating Mucopolysaccharidoses
by: Sofia Carvalho, et al.
Published: (2023-04-01)

Cathepsins in the Pathophysiology of Mucopolysaccharidoses: New Perspectives for Therapy
by: Valeria De Pasquale, et al.
Published: (2020-04-01)

Gene Therapy for Neuronopathic Mucopolysaccharidoses: State of the Art
by: María José de Castro, et al.
Published: (2021-08-01)

Airway and Anaesthetic Management of Adult Patients with Mucopolysaccharidoses Undergoing Cardiac Surgery
by: David Mayhew, et al.
Published: (2024-02-01)

Brain diffusion alterations in patients with COVID-19 pathology and neurological manifestations
by: Anna Caroli, et al.
Published: (2023-01-01)

Emerging Approaches for Fluorescence-Based Newborn Screening of Mucopolysaccharidoses
by: Rajendra Singh, et al.
Published: (2020-05-01)

Laryngeal, Tracheal, and Bronchial Disease in the Mucopolysaccharidoses: Endoscopic Study
by: Paulo Pires de Mello, et al.
Published: (2020-01-01)

Treatment of Neuronopathic Mucopolysaccharidoses with Blood–Brain Barrier-Crossing Enzymes: Clinical Application of Receptor-Mediated Transcytosis
by: Hiroyuki Sonoda, et al.
Published: (2022-06-01)

Digital Microfluidics in Newborn Screening for Mucopolysaccharidoses: A Progress Report
by: Jon Washburn, et al.
Published: (2020-10-01)

Intravenous Enzyme Replacement Therapy in Mucopolysaccharidoses: Clinical Effectiveness and Limitations
by: Rossella Parini, et al.
Published: (2020-04-01)

Neonatal Screening for MPS Disorders in Latin America: A Survey of Pilot Initiatives
by: Francyne Kubaski, et al.
Published: (2020-11-01)

Mucopolysaccharidoses in northern Brazil: Targeted mutation screening and urinary glycosaminoglycan excretion in patients undergoing enzyme replacement therapy
by: Gustavo M. Viana, et al.
Published: (2011-01-01)

Identifying the genetic causes of phenotypically diagnosed Pakistani mucopolysaccharidoses patients by whole genome sequencing
by: Rutaba Gul, et al.
Published: (2023-04-01)

Premier listening to chatter on MPs
by: Goh, Pei Pei
Published: (2022)

Glycosphingolipid levels and glucocerebrosidase activity are altered in normal aging of mouse brain
by: Hallett, PJ, et al.
Published: (2018)